It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.
Philippe Monteyne, MD, PhD,
Advertisement
Philippe Monteyne, MD, PhD, is the senior vice president of global vaccine development all at GlaxoSmithKline Biologicals
Articles by Philippe Monteyne, MD, PhD,
Advertisement
Latest Updated Articles
Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant SystemsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
Establishing Risk Assessments for AI in Bio-Manufacturing
5
